Encompass Health Corp
NYSE:EHC
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
64.33
103.53
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Encompass Health Corp
Encompass Health Corp
EPS (Diluted)
Encompass Health Corp
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Encompass Health Corp
NYSE:EHC
|
EPS (Diluted)
$4
|
CAGR 3-Years
0%
|
CAGR 5-Years
5%
|
CAGR 10-Years
11%
|
|
|
Universal Health Services Inc
NYSE:UHS
|
EPS (Diluted)
$15
|
CAGR 3-Years
6%
|
CAGR 5-Years
13%
|
CAGR 10-Years
12%
|
|
|
Select Medical Holdings Corp
NYSE:SEM
|
EPS (Diluted)
$2
|
CAGR 3-Years
-10%
|
CAGR 5-Years
22%
|
CAGR 10-Years
12%
|
|
|
Tenet Healthcare Corp
NYSE:THC
|
EPS (Diluted)
$32
|
CAGR 3-Years
48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
HCA Healthcare Inc
NYSE:HCA
|
EPS (Diluted)
$22
|
CAGR 3-Years
4%
|
CAGR 5-Years
18%
|
CAGR 10-Years
19%
|
|
|
Ensign Group Inc
NASDAQ:ENSG
|
EPS (Diluted)
$4
|
CAGR 3-Years
7%
|
CAGR 5-Years
16%
|
CAGR 10-Years
17%
|
|
Encompass Health Corp
Glance View
Encompass Health Corp. is a leading provider of integrated healthcare services, specializing in inpatient rehabilitation and home health services across the United States. Founded in 1984, the company has evolved from a single rehabilitation hospital into a robust network of facilities catering to patients with complex medical needs. With over 150 inpatient rehabilitation hospitals and numerous home health locations, Encompass Health has carved out a significant niche in the post-acute care market. Its comprehensive rehabilitation programs are designed to enhance recovery outcomes for patients who have suffered strokes, traumatic injuries, or major surgeries, and it is consistently recognized for delivering high-quality care, evidenced by its strong ratings from independent health organizations. For investors, Encompass Health represents a compelling opportunity in the healthcare sector, underscored by its consistent revenue growth and strategic expansion initiatives. The company’s commitment to innovation, such as implementing advanced technologies in patient care and streamlining operations, positions it well to capitalize on the increasing demand for post-acute care services driven by an aging population. With a robust financial track record, including steady cash flow and a focus on improving profitability, Encompass Health stands out as a resilient player in a growing market. As healthcare continues to shift towards value-based care, Encompass Health's strategic focus on quality patient outcomes and operational efficiency makes it an appealing prospect for investors looking for stability and growth in their portfolios.
See Also
What is Encompass Health Corp's EPS (Diluted)?
EPS (Diluted)
4.1
USD
Based on the financial report for Sep 30, 2024, Encompass Health Corp's EPS (Diluted) amounts to 4.1 USD.
What is Encompass Health Corp's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
11%
Over the last year, the EPS (Diluted) growth was 18%.
You don't have any saved screeners yet
